Intrahepatic Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Intrahepatic Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Percutaneous Cholangiopancreatoscopy Registry
Clinical trial registry entry for a Percutaneous Cholangiopancreatoscopy Registry; the study is listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial evaluating FOLFOX-HAIC combined with donafenib and pucotenlimab as first-line treatment for unresectable intrahepatic…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
A prospective evaluation study assessing 68Ga-FAPI PET imaging for biliary cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma [Phase 2]
Phase 2 study evaluating hepatic arterial infusion of gemcitabine and oxaliplatin as second-line therapy for non-resectable, non-metastatic …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma [Phase 2, Phase 3]
This clinical trial update indicates that the HMPL-453 tartrate study is being evaluated in advanced intrahepatic cholangiocarcinoma (Phase …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions [NA]
Clinical trial update for contrast-enhanced MRI to detect benign and malignant liver lesions; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Infusion System for Hepatic Cancer [NA]
An ongoing clinical trial is evaluating an infusion system for hepatic cancers, including colorectal cancer with liver metastases and intrah…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN [NA]
A clinical trial is evaluating PET imaging with zirconium-labelled girentuximab in patients with hepatocellular carcinoma, intrahepatic chol…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC) [Phase 2]
Phase 2 trial update shows ongoing immunotherapy combined with yttrium-90 SIRT therapy for intrahepatic cholangiocarcinoma; the study is cur…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of iparomlimab and tuvonralimab with GemOX chemotherapy and lenvatinib as conversion thera…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC [Phase 2]
Phase 2 trial evaluating Apatinib and Adebrelimab with chemotherapy for unresectable intrahepatic cholangiocarcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [Phase 2]
Phase II trial update for Cadonilimab plus Capecitabine as adjuvant therapy for combined hepatocellular-cholangiocarcinoma and intrahepatic …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Interventional AI-Human Collaboration for Liver Tumor Diagnosis [NA]
Completed interventional clinical trial examining an AI–human collaboration approach for diagnosing liver tumors. The study encompasses hepa…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy [Phase 2]
Phase 2 trial comparing short-stitch versus traditional suture to prevent incisional hernia after open hepatectomy (liver resection); curren…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma [Phase 1]
This clinical trial update describes a Phase 1 study evaluating radioembolization combined with tremelimumab and durvalumab for locally adva…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Dosimetric Differences and Clinical Significance Analysis Between Body Gamma Knife and VMAT Radiotherapy for Primary Liver Cance
This clinical trial update assesses dosimetric differences between Body Gamma Knife and VMAT radiotherapy for primary liver cancers. It also…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST [NA]
A randomized trial evaluating surgical decision-making guided by TDTP-RECIST for intrahepatic cholangiocarcinoma; the study is currently not…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
This clinical trial is evaluating a cell-free DNA methylation blood test for screening biliary tract cancers and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
This clinical trial POELH-III evaluates preoperative evaluation of lymph nodes in cholangiocarcinoma and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors [Phase 2, Phase 3]
Updates on a Phase II-III neoadjuvant trial combining toripalimab, lenvatinib, and GEMOX for resectable intrahepatic cholangiocarcinoma; stu…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC [Phase 2]
Phase 2 trial update of iparomlimab and tuvonralimab with gemcitabine/cisplatin for advanced intrahepatic cholangiocarcinoma, not yet recrui…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. [Phase 2]
Phase 2 trial evaluating cryoablation combined with SHR-1701 and famitinib for advanced intrahepatic cholangiocarcinoma; the study is not ye…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma [Phase 2]
A Phase 2 clinical trial evaluating preoperative CISGEM (cisplatin + gemcitabine) plus Rilvegostomig for high-risk resectable intrahepatic c…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer [Phase 2]
Phase 2 clinical trial assessing selective internal radiation therapy with capecitabine for resectable intrahepatic cholangiocarcinoma, curr…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
This clinical trial update describes an exploratory study at Peking Union Medical College Hospital. It aims to integrate multimodal imaging …